Rosario Cerundolo

Prof. Rosario Cerundolo

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2013 in In Practice
Verified
Journal Article
Open access
PDF file
RCRosario Cerundolo
Rosario Cerundolo
Cheyletiellaspecies,Demodexspecies,Sarcoptes scabieiandOtodectes cynotisare briefly reviewed. It also offers guidance on choosing the safest and the most efficient treatment for parasitic skin diseases in small animals as part of the investigation of pruritic animals.

1 July 2025 in Microbiology Research
Verified
Journal Article
Open access
PDF file
IPIoanna Papadogiannaki
Ioanna Papadogiannaki
RCRosario Cerundolo
Rosario Cerundolo
JPJennifer Plant
Jennifer Plant
EVElizabeth Villiers
Elizabeth Villiers
JLJenny Littler
Jenny Littler
PSPanagiotis Sgardelis
Panagiotis Sgardelis
Pseudomonas aeruginosa otitis is common in dogs and antibiotic-resistant strains are often isolated. We are unaware of reports evaluating the combination of silver sulfadiazine (SSD) with a biofilm disruptor solution containing Tris-EDTA (tromethamine-ethylenediaminetetraacetic acid) and N-acetylcysteine (Tris-NAC). Forty-eight P. aeruginosa strains from dogs with suppurative otitis were analysed using the agar well diffusion method. A volume of 70 μL of Tris-NAC, a water solution of 10% SSD and their combination in equal amount was pipetted into the designated wells. After incubation, the diameter of the inhibition zone was measured. A synergy experiment using the checkerboard assay was performed to look at any potential synergistic effects of SSD and Tris-NAC against only 10 randomly selected isolates of P. aeruginosa. The samples tested with Tris-NAC + 10% SSD solution, compared with the samples tested with 10% SSD alone, demonstrated significantly higher inhibition zones against P. aeruginosa, p < 0.00001. The checkerboard assay results showed an additive effect between the two compounds. The use of 10% SSD could be evaluated as a therapeutic tool against strains of P. aeruginosa if combined with Tris-NAC.